IMRX vs BIIB: Which Stock is Better?
Side-by-side comparison of Immuneering Corp and Biogen Inc in 2026
IMRX
Immuneering Corp
$5.70
BIIB
Biogen Inc
$180.54
Key Metrics Comparison
| Metric | IMRX | BIIB | Winner |
|---|---|---|---|
| Market Cap | $356.88M | $26.50B | BIIB |
| P/E Ratio | N/A | 20.54 | BIIB |
| EPS (TTM) | $N/A | $8.79 | BIIB |
| Revenue Growth | -1.0% | -0.1% | BIIB |
| Gross Margin | 34907.7% | 78.9% | IMRX |
Analyze IMRX
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMRX or BIIB a better investment?
Comparing IMRX and BIIB: Immuneering Corp has a market cap of $356.88M while Biogen Inc has $26.50B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMRX and BIIB?
IMRX (Immuneering Corp) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMRX or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMRX or BIIB?
BIIB has higher revenue growth at -0.1% vs -1.0% for IMRX.
Which company is more profitable: IMRX or BIIB?
Immuneering Corp (IMRX) has higher gross margins at 34907.7% compared to 78.9% for BIIB.
Which is the larger company: IMRX or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.50B compared to $356.88M for IMRX.
Should I buy IMRX or BIIB in 2026?
Both IMRX and BIIB have investment merit. IMRX trades at $5.70 while BIIB trades at $180.54. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMRX and BIIB stock?
Key differences: Market Cap ($356.88M vs $26.50B), P/E Ratio (N/A vs 20.5x), Revenue Growth (-1.0% vs -0.1%), Gross Margin (34907.7% vs 78.9%).